Renal impairment in chronic cigarette smokers.

Journal of the American Society of Nephrology : JASN
G GambaroB Baggio

Abstract

To determine the effect of chronic cigarette smoking on renal function, a cross-sectional study was carried out with 30 subjects who had no known vascular disease risk factor other than cigarette smoking, and 24 age- and sex-matched controls without any vascular risk factor including cigarette smoking. Renal function by radionuclide studies of renal plasma flow, GFR, and plasma endothelin-1 concentration was determined. Compared with nonsmokers, smokers had a renal function impairment characterized by a normal GFR and a significant reduction in renal plasma flow as reflected by MAG3 clearance (199.20 +/- 58.85 ml/min per 1.73 m2 versus 256.54 +/- 60.14 ml/min per 1.73 m2; t = 3.52, P < 0.001). MAG3 clearance was significantly correlated with age and smoking. The renal dysfunction was associated with an increase in plasma endothelin-1 concentration (21.56 +/- 1.15 pmol/L versus 25.01 +/- 3.21 pmol/L; t = 5.00, P < 0.001). Former smokers as well had similar, although milder, abnormalities. In conclusion, cigarette smokers manifest an impairment of renal function, suggesting that smoke may have a detrimental effect on renal function.

Citations

Jun 22, 2000·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·J M Halimi, A Mimran
Sep 29, 2000·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·S R OrthE Ritz
Mar 28, 2002·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Naoki MatsumotoYoshiki Nishizawa
Oct 22, 2003·Journal of the American Society of Nephrology : JASN·Melanie K HarounJosef Coresh
Apr 7, 2000·Journal of the American Society of Nephrology : JASN·Bertram L Kasiske, Dagmar Klinger
Sep 27, 2000·Journal of the American Society of Nephrology : JASN·L Shannon HollidayAlex J Brown
Feb 19, 2002·Kidney International·Karl LhottaFlorian Kronenberg
Aug 21, 2002·Current Opinion in Nephrology and Hypertension·Stephan R Orth, Eberhard Ritz
Jun 28, 2003·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Wendy Weinstock BrownJohn M Flack
Jul 3, 2003·Seminars in Nephrology·Donald E Wesson
Nov 6, 2003·Annals of Epidemiology·Suma Vupputuri, Dale P Sandler
Jul 17, 2001·Transplantation·R S SungR M Merion
Jun 1, 2002·Journal of the American Society of Nephrology : JASN·Stephan R Orth
Oct 25, 2002·Journal of the American Society of Nephrology : JASN·Bruno BaggioPaola Fioretto
Dec 2, 2004·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·B BaggioUNKNOWN ILSA Working Group
Jul 5, 2003·Epidemiology·Bénédicte StengelFrederick L Brancati
Sep 15, 2001·The Tohoku Journal of Experimental Medicine·S R OrthE Ritz
Aug 20, 2005·Nephrology·Eberhard Ritz, Vedat Schwenger
Apr 26, 2006·Nephron. Clinical Practice·Leszek TylickiWalter H Horl
Jul 21, 2004·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Giorgio FuianoMichele Andreucci
Jan 17, 2007·Metabolism: Clinical and Experimental·Futoshi AnanHironobu Yoshimatsu
Mar 17, 2007·Current Hypertension Reports·Carlos Mercado, Edgar A Jaimes
Mar 28, 2007·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Kelly V LiangSanjeev Sethi
Jun 2, 2007·American Journal of Nephrology·Charlotte Jones-BurtonJeffrey C Fink
Apr 9, 1999·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·G Remuzzi
Mar 31, 2000·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·M RegaladoD E Wesson
Mar 31, 2000·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·E Ritz, S R Orth
Aug 2, 2008·Toxicology and Industrial Health·E OzanT Kuloglu
Jun 21, 2008·Clinical and Experimental Pharmacology & Physiology·Sahar M El-GowillyMahmoud M El-Mas
Oct 16, 2008·Kidney International·Amy K MottlKari E North
Jul 7, 2005·Pathology Oncology Research : POR·Nil CulhaciIzzet Kocak
Mar 6, 2009·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Hyung-Jin YoonSuhnggwon Kim
Apr 29, 2009·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Justine BacchettaPierre Cochat
Mar 3, 2001·Minerva urologica e nefrologica = The Italian journal of urology and nephrology·R CardelliG C Priasca
Sep 22, 2009·Canadian Journal of Physiology and Pharmacology·Mahmoud M El-MasAbdel-Rheem M Ghazal

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.